Clinical Trial Update: Phase II Study of Perifosine in Patients With Refractory and Relapsed Leukemia [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase II clinical trial evaluating perifosine in patients with refractory or relapsed leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Perifosine (perifosine)

Snippet

Sponsor: AEterna Zentaris | Conditions: Leukemia | Phase 2 | Status: COMPLETED